There is increasing interest in lifestyle modification and integrative medicine approaches to treat and/or prevent mild cognitive impairment (MCI) and Alzheimer’s disease and related dementias (ADRD).
Objective:
To address the need for a quantifiable measure of brain health, we created the Resilience Index (RI).
Methods:
This cross-sectional study analyzed 241 participants undergoing a comprehensive evaluation including the Clinical Dementia Rating and neuropsychological testing. Six lifestyle factors including physical activity, cognitive activity, social engagements, dietary patterns, mindfulness, and cognitive reserve were combined to derive the RI (possible range of scores: 1–378). Psychometric properties were determined.
Results:
The participants (39 controls, 75 MCI, 127 ADRD) had a mean age of 74.6±9.5 years and a mean education of 15.8±2.6 years. The mean RI score was 138.2±35.6. The RI provided estimates of resilience across participant characteristics, cognitive staging, and ADRD etiologies. The RI showed moderate-to-strong correlations with clinical and cognitive measures and very good discrimination (AUC: 0.836; 95% CI: 0.774–0.897) between individuals with and without cognitive impairment (diagnostic odds ratio = 8.9). Individuals with high RI scores (> 143) had better cognitive, functional, and behavioral ratings than individuals with low RI scores. Within group analyses supported that controls, MCI, and mild ADRD cases with high RI had better cognitive, functional, and global outcomes than those with low RI.
Conclusion:
The RI is a brief, easy to administer, score and interpret assessment of brain health that incorporates six modifiable protective factors. Results from the RI could provide clinicians and researchers with a guide to develop personalized prevention plans to support brain health.
GalvinJE (2018) Using informant and performance screening methods to detect mild cognitive impairment and dementia. Curr Rep Gerontol7, 19–25.
4.
GalvinJE, ToleaMI, ChrisphonteSC (2020) What do older adults do with results from dementia screening. PLoS One15, e0235534.
5.
GalvinJE (2017) Prevention of Alzheimer’s disease: Lessons learned and applied. J Am Geriatr Soc65, 2128–2133.
6.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging–Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
7.
MitchellS, RidleySH, SanchoRM, NortonM (2017) The future of dementia risk reduction research: Barriers and solutions. J Public Health39, e275–e281.
8.
O’DonnellCA, BrowneS, PierceM, McConnachieA, DeckersK, van BoxtelMPJ, ManeraV, KohlerS, RedmondM, VerheyFRJ, van den AkkerM, PowerK, IrvingK, In-MINDD Team (2015) Reducing dementia risk by targeting modifiable risk factors in mid-life: Study protocol for the Innovative Midlife Intervention for Dementia Deterrence (In-MINDD) randomised controlled feasibility trial. Pilot Feasibility Stud1, 40.
GaitánJM, BootsEA, DoughertyRJ, MaY, EdwardsDF, MitchellCC, ChristianBT, CookDB, OkonkwoOC (2020) Protocol of Aerobic Exercise and Cognitive Health (REACH): A pilot study. J Alzheimers Dis Rep4, 107–121.
12.
BlockerEM, FryAC, LuebbersPE, BurnsJM, Perales-PuchaltJ, HansenDM, VidoniED (2020) Promoting Alzheimer’s risk-reduction through community-based lifestyle education and exercise in Rural America: A pilot intervention. Kans J Med13, 179–185.
13.
VidoniED, PeralesJ, AlshehriM, GilesAM, SiengsukonCF, BurnsJM (2019) Aerobic exercise sustains performance of Instrumental Activities of Daily Living in early-stage Alzheimer disease. J Geriatr Phys Ther42, E129–E134.
14.
YatesLA, ZiserS, SpectorA, OrrellM (2016) Cognitive leisure activities and future risk of cognitive impairment and dementia: Systematic review and metanalysis. Int Psychogeriatr28, 1791–1806.
15.
GalvinJE, ToleaMI, ChrisphonteS (2021) The Cognitive & Leisure Activity Scale (CLAS): A new measure to quantify cognitive activities in older adults with and without cognitive impairment. (N Y)7, e12134.
16.
ChengST (2016) Cognitive reserve and the prevention of dementia: The role of physical and cognitive activities. Curr Psychiatry Rep18, 85.
17.
HackettRA, SteptoeA, CadarD, FancourtD (2019) Social engagement before and after dementia diagnosis in the English Longitudinal Study of Ageing. PLoS One14, e0220195.
18.
BiddleKD, d’Oleire UquillasF, JacobsHIL, ZideB, KirnDR, RentzDM, JohnsonKA, SperlingRA, DonovanNJ (2019) Social engagement and amyloid-β-related cognitive decline in cognitively normal older adults. Am J Geriatr Psychiatry27, 1247–1256.
19.
KhalsaDS (2015) Stress, meditation, and Alzheimer’s disease prevention: Where the evidence stands. J Alzheimers Dis48, 1–12.
20.
InnisAD, ToleaMI, GalvinJE (2021) The effect of baseline patient and caregiver mindfulness on dementia outcomes. J Alzheimers Dis79, 1345–1367.
21.
GustafsonDR, BäckmanK, ScarmeasN, SternY, ManlyJJ, MayeuxR, GuY (2020) Dietary fatty acids and risk of Alzheimer’s disease and related dementias: Observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP). Alzheimers Dement16, 1638–1649.
22.
DhanaK, EvansDA, RajanKB, BennettDA, MorrisMC (2020) Healthy lifestyle and the risk of Alzheimer dementia: Findings from 2 longitudinal studies. Neurology95, e374–e383.
RitchieCW, MolinuevoJL, TruyenL, SatlinA, Van der GeytenS, LovestoneS; European Prevention of Alzheimer’s Dementia (EPAD) Consortium (2016) Development of interventions for the secondary prevention of Alzheimer’s dementia: The European Prevention of Alzheimer’s Dementia (EPAD) project. Lancet Psychiatry3, 179–186.
25.
RosenbergA, MangialascheF, NganduT, SolomonA, KivipeltoM (2020) Multidomain interventions to prevent cognitive impairment, Alzheimer’s disease, and dementia: From FINGER to World-Wide FINGERS. J Prev Alzheimers Dis7, 29–36.
26.
AhnHI, HyunMK (2019) Effectiveness of integrative medicine program for dementia prevention on cognitive function and depression of elderly in a public health center. Integr Med Res8, 133–137.
27.
GalvinJE (2018) Advancing personalized treatment of Alzheimer’s disease: A call for the N-of-1 trial design. Future Neurol13, 151–160.
ChapkoD, McCormackR, BlackC, StaffR, MurrayA (2018) Life-course determinants of cognitive reserve (CR) in cognitive aging and dementia - a systematic literature review. Aging Ment Health22, 915–926.
30.
GalvinJE, ToleaMI, MooreC, ChrisphonteS (2020) The Number Symbol Coding Task: A brief measure of executive function to detect dementia and cognitive impairment. PLoS One15, e0242233.
31.
VonkJMJ, Arce RenteríaM, AvilaJF, SchupfN, NobleJM, MayeuxR, BrickmanAM, ManlyJJ (2019) Secular trends in cognitive trajectories of diverse older adults. Alzheimers Dement15,, 1576–1587.
ZahodneLB, MayedaER, HohmanTJ, FletcherE, RacineAM, GavettB, ManlyJJ, SchupfN, MayeuxR, BrickmanAM, MungasD (2019) The role of education in a vascular pathway to episodic memory: Brain maintenance or cognitive reserve?Neurobiol Aging84, 109–118.
34.
ZahodneLB, ManlyJJ, SmithJ, SeemanT, LachmanME (2017) Socioeconomic, health, and psychosocial mediators of racial disparities in cognition in early, middle, and late adulthood. Psychol Aging32, 118–130.
35.
ZahodneLB, SternY, ManlyJJ (2015) Differing effects of education on cognitive decline in diverse elders with low versus high educational attainment. Neuropsychology29, 649–657.
36.
GhaffarO, FiatiM, FeinsteinA (2012) Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS One7,, e47206.
37.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43,, 2412–2414.
38.
GalvinJE, ValoisL, ZweigY (2104) Collaborative transdisciplinary team approach for dementia care. Neurodegener Dis Manag4, 455–469.
39.
HollingsheadAB (1957) Two factor index of social position. Yale University Press, New Haven.
40.
BeeklyDL, RamosEM, LeeWW, DeitrichWD, JackaME, WuJ, HubbardJL, KoepsellTD, MorrisJC, KukullWA, NIA Alzheimer’s Disease Centers (2007) The National Alzheimer’s Coordinating Center (NACC) database: The Uniform Data Set. Alzheimer Dis Assoc Disord21, 249–258.
41.
WeintraubS, BesserL, DodgeHH, TeylanM, FerrisS, GoldsteinFC, GiordaniB, KramerJ, LoewensteinD, MarsonD, MungasD, SalmonD, Welsh-BohmerK, ZhouXH, ShirkSD, AtriA, KukullWA, PhelpsC, MorrisJC (2018) Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord32, 10–17.
42.
GoetzCG, TilleyBC, ShaftmanSR, StebbineGT, FahnS, Martinez-MartinP, PoeweW, SampaioC, SternMB, DodelR, DuboisB, HollowayR, JankovicJ, KulisevskyJ, LangAE, LeesA, LeurgansS, LeWittPA, NyenhuisD, OlanowCW, RascolO, SchragA, TeresiJA, van HiltenJJ, LapelleN; Movement Disorder Society UPDRS Revision Task Force (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord23, 2129–2170.
43.
CharlsonME, PompeiP, AlesKL, MacKenzieCR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis40, 373–383.
44.
GrollDL, HelandD, CaeserM, WrightJG (2006) Assessment of long-term physical function in acute respiratory distress syndrome (ARDS) patients: Comparison of the Charlson Comorbidty index and the functional comorbidity index. Am J Phys Med7, 574–581.
45.
WilkinsCH, RoeCM, MorrisJC (2010) A brief clinical tool to assess physical function: The mini-physical performance test. Arch Gerontol Geriatr50, 96–100.
46.
FriedLP, TangenCM, WalstonJ, NewmanAB, HirschC, GottdienerJ, SeemanT, TracyR, KopWJ, BurkeG, McBurnieMA; Cardiovascular Health Study Collaborative Research Group (2001) Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci56, M146–156.
47.
RosenWG, TerryRD, FuldPA, KatzmanR, PeckA (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol7, 486–488.
48.
ToleaMI, HeoJ, ChrisphonteS, GalvinJE (2021) A modified CAIDE risk score as a screening tool for cognitive impairment in older adults. J Alzheimers Dis82, 1755–1768.
49.
GalvinJE (2015) The Quick Dementia Rating System (QDRS): A rapid dementia staging tool. Alzheimers Dement (Amst)1, 249–259.
50.
TappenRM, RosselliM, EngstromG (2010) Evaluation of the Functional Activities Questionnaire (FAQ) in cognitive screening across four American ethnic groups. Clin Neuropsychol24, 646–661.
51.
KauferD, CummingsJ, KetchelP, SmithV, MacMillanA, ShelleyT, LopezOL, DeKoskyST (2000) Validation of the NPI-Q a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci12, 233–239.
52.
FeenyDH, FurlongWJ, TorranceGW, GoldsmithCH, ZhuZ, DePauwS, DentonM, BoyleM (2002) Multi-attribute and single-attribute utility functions for the Health Utilities Index Mark 3 System. Medical Care40, 113–128.
NasreddineZS, PhillipsNA, BédirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc53, 695–699.
55.
ShapiroAM, BenedictRH, SchretlenD, BrandtJ (1999) Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. . Clin Neuropsychol13, 348–358.
56.
ReitanRM (1958) Validity of the trail making test as an indication of organic brain damage. Perceptual Motor Skills8, 271–276.
57.
SnaithRP (2003) The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes1, 29.
58.
GalvinJE, ToleaMI, ChrisphonteS (2020) Using a patient-reported outcome to improve detection of cognitive impairment and dementia: The patient version of the Quick Dementia Rating System (QDRS). PLoS One15, e0240422.
59.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManyJF, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
GalvinJE, ToleaMI, RosenfeldA, ChrisphonteS (2020) The Quick Physical Activity Rating (QPAR): A brief assessment of physical activity in older adults with and without cognitive impairment. PLoS One15, e0241641.
64.
LiMJ, BlackDS, GarlandEL (2016) The Applied Mindfulness Process Scale (AMPS): A process measure for evaluating mindfulness-based interventions. Pers Individ Dif93, 6–15.
65.
RossDE, OchsAL, TateDF, TokacU, SeabaughJ, AbildskovTJ, BiglerED (2018) High correlations between MRI brain volume measurements based on NeuroQuant(®) and FreeSurfer. Psychiatry Res Neuroimaging278, 69–76.
66.
PerssonK, BarcaML, CavallinL, BrækhusA, KnapskogAB, SelbækG, EngedalK (2018) Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer’s disease. Acta Radiol59, 997–1001.
67.
HeisterD, BrewerJB, MagdaS, BlennowK, McEvoyLK (2011) Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology77, 1619–1628.
68.
GalvinJE, FaganAM, HoltzmanDM, MintunMA, MorrisJC (2010) Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain133, 3290–3300.
GlasAS, LijmerJG, PrinsMH, BonselGJ, BossuytPM (2003) The diagnostic odds ratio: A single indicator of test performance. J Clin Epidemiology56, 1129–1135.
71.
HarrellF, CaliffR, PryorD, LeeK, RosatiR (1982) Evaluating the yield of medical tests. JAMA247, 2543–2546.
GrandeG, QiuC, FratiglioniL (2020) Prevention of dementia in an ageing world: Evidence and biological rationale. Ageing Res Rev64, 01045.
74.
Arenaza-UrquijoEM, VemuriP (2020) Improving the resistance and resilience framework for aging and dementia studies. Alzheimers Res Ther12, 41.
75.
DugganMR, ParikhV (2021) Microglia and modifiable life factors: Potential contributions to cognitive resilience in aging. Behav Brain Res405, 113207.
76.
FratiglioniL, MarsegliaA, DekhtyarS (2020) Ageing without dementia: Can stimulating psychosocial and lifestyle experiences make a difference?Lancet Neurol19, 533–543.
77.
Bartrés-FazD, Arenaza-UrquijoE, EwersM, BellevilleS, ChételatG, FranzmeierN, GonneaudJ, de EchevarriJMG, OkonkwoO, SchultzS, ValenzuelaM, SternY, VemuriP (2020) Theoretical frameworks and approaches used within the Reserve, Resilience and Protective Factors professional interest area of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment. Alzheimers Dement12, e12115.
78.
TesiN, van der LeeSJ, HulsmanM, JansenIE, StringaN, van SchoorNM, ScheltensP, van der FlierWM, HuismanM, ReindersMJT, HolstegeH (2020) Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease. Transl Psychiatry10, 332.
79.
RosaG, GiannottiC, MartellaL, MassaF, SerafiniG, PardiniM, NobiliFM, MonacelliF, Disease Management Team on Dementia of the IRCCS Ospedale Policlinico San Martino (Genoa, I) (2020) Brain aging, cardiovascular diseases, mixed dementia, and frailty in the oldest old: From brain phenotype to clinical expression. J Alzheimers Dis75, 1083–1103.
YuL, TasakiS, SchneiderJA, ArfanakisK, DuongDM, WingoAP, WingoTS, KearnsN, ThatcherGRJ, SeyfriedNT, LeveyAI, De JagerPL, BennettDA (2020) Cortical proteins associated with cognitive resilience in community-dwelling older persons. JAMA Psychiatry77, 1–9.
82.
BusattoGF, de Gobbi PortoFH, FariaDP, SquarzoniP, CoutinhoAM, GarcezAT, RosaPGP, da CostaNA, CarvalhoCL, TorralboL, de Almeida HernandesJR, OnoCR, BruckiSMD, NitriniR, BuchpiguelCA, Souza DuranFL, ForlenzaOV (2020) In vivo imaging evidence of poor cognitive resilience to Alzheimer’s disease pathology in subjects with very low cognitive reserve from a low-middle income environment. Alzheimers Dement12, e12122.
WindleG, HoareZ, WoodsB, HuismanM, BurholtV (2021) A longitudinal exploration of mental health resilience, cognitive impairment, and loneliness. Int J Geriatr Psychiatry36, 1020–1028.
Physical Activity Guidelines Advisory Committee (2008) Physical activity guidelines advisory committee report. US Department of Health and Human Services, 2008, A1-H14, Washington, DC.
87.
FalckRS, McDonaldSM, BeetsMW, BrazendaleK, Liu-AmbroseT (2016) Measurement of physical activity in older adult interventions: A systematic review. Br J Sports Med50, 464–470.
88.
ToleaMI, MorrisJC, GalvinJE (2015) Longitudinal associations between physical and cognitive function among community-dwelling older adults. PLoS One10, e0122878.
89.
ToleaMI, MorrisJC, GalvinJE (2016) Trajectory of physical functional decline by type of dementia. Alzheimer Dis Assoc Disord30, 60–66.
90.
NewbergAB, WinteringN, KhalsaDS, RoggenkampH, WaldmanMR (2010) Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: A preliminary study. J Alzheimers Dis20, 517–526.
91.
Quintana-HernandezDJ, Miro-BarrachinaMT, Ibanez-FernandezIJ, Santana-DelPinoA, Quintana-MontesdeocaMP, Rodriguez-de VeraB, Morales-CasanovaD, Perez-VieitezMDC, Rodriguez-GarciaJ, Bravo-CaradujeN (2016) Mindfulness in the maintenance of cognitive capacities in Alzheimer’s disease: A randomized clinical trial. J Alzheimers Dis50, 217–232.
92.
Montero-OdassoM, IsmailZ, LivingstonG (2020) One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case “for” and “against”. Alzheimers Res Ther12, 81.
